|
RASSF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.293600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.244400E-01 |
| Normal-vs-Stage2 |
4.201000E-01 |
| Normal-vs-Stage3 |
7.386000E-01 |
| Normal-vs-Stage4 |
8.154800E-01 |
| Stage1-vs-Stage2 |
1.141950E-01 |
| Stage1-vs-Stage3 |
2.633600E-01 |
| Stage1-vs-Stage4 |
6.230200E-01 |
| Stage2-vs-Stage3 |
6.300400E-01 |
| Stage2-vs-Stage4 |
9.038800E-01 |
| Stage3-vs-Stage4 |
9.102400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.652600E-01 |
| Normal-vs-AfricanAmerican |
2.917600E-01 |
| Normal-vs-Asian |
1.751230E-01 |
| Caucasian-vs-AfricanAmerican |
8.153800E-02 |
| Caucasian-vs-Asian |
5.910800E-01 |
| AfricanAmerican-vs-Asian |
3.065600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.269400E-01 |
| Normal-vs-Female |
1.332000E-01 |
| Male-vs-Female |
2.606300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.433600E-01 |
| Normal-vs-Extreme_Weight |
3.644500E-02 |
| Normal-vs-Obese |
1.921010E-01 |
| Normal-vs-Extreme_Obese |
3.656900E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.159000E-01 |
| Normal_Weight-vs-Obese |
4.263500E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.345600E-01 |
| Extreme_Weight-vs-Obese |
6.723900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.939560E-01 |
| Obese-vs-Extreme_Obese |
1.618570E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.011580E-01 |
| Normal-vs-Age(41-60Yrs) |
3.027000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.767010E-01 |
| Normal-vs-Age(81-100Yrs) |
1.398240E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.048400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.776800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.059000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.889870E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.649969999995E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.897000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.288000E-01 |
| Normal-VS-Type2 PRCC |
3.733600E-01 |
| Normal-VS-KIRP CIMP |
6.192000E-02 |
| Normal-VS-Unclassified PRCC |
3.184000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.465400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.603300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.350470E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.516400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.261780E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.651400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.031000E-01 |
| Normal-vs-N1 |
3.904800E-01 |
| Normal-vs-N2 |
3.761400E-01 |
| N0-vs-N1 |
2.190600E-01 |
| N0-vs-N2 |
1.484830E-01 |
| N1-vs-N2 |
6.588800E-01 |
|
|
